CXCR2 and cancer: In conclusion, this study provides significant evidence that CXCR1 and CXCR2 antagonism with G31P inhibits lung cancer growth and metastasis, through directly restraining cancer cell proliferation and migration as well as stimulating apoptosis, but also indirectly modulating tumor microenvironment by suppressing angiogenesis.